rs4512966

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001846.4(COL4A2):​c.478-174T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.508 in 152,082 control chromosomes in the GnomAD database, including 19,911 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 19911 hom., cov: 33)

Consequence

COL4A2
NM_001846.4 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.102

Publications

9 publications found
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
  • porencephaly 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • COL4A1 or COL4A2-related cerebral small vessel disease
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001846.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 13-110429711-T-C is Benign according to our data. Variant chr13-110429711-T-C is described in ClinVar as Benign. ClinVar VariationId is 1271252.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.564 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001846.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A2
NM_001846.4
MANE Select
c.478-174T>C
intron
N/ANP_001837.2P08572

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A2
ENST00000360467.7
TSL:5 MANE Select
c.478-174T>C
intron
N/AENSP00000353654.5P08572
COL4A2
ENST00000619688.3
TSL:6
c.*1077T>C
3_prime_UTR
Exon 7 of 7ENSP00000496868.2A0A3B3IRV2
COL4A2
ENST00000714399.1
c.478-174T>C
intron
N/AENSP00000519666.1A0AAQ5BHW7

Frequencies

GnomAD3 genomes
AF:
0.508
AC:
77233
AN:
151964
Hom.:
19891
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.570
Gnomad AMI
AF:
0.609
Gnomad AMR
AF:
0.484
Gnomad ASJ
AF:
0.557
Gnomad EAS
AF:
0.411
Gnomad SAS
AF:
0.473
Gnomad FIN
AF:
0.447
Gnomad MID
AF:
0.525
Gnomad NFE
AF:
0.491
Gnomad OTH
AF:
0.506
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.508
AC:
77314
AN:
152082
Hom.:
19911
Cov.:
33
AF XY:
0.505
AC XY:
37557
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.570
AC:
23655
AN:
41488
American (AMR)
AF:
0.484
AC:
7405
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.557
AC:
1932
AN:
3470
East Asian (EAS)
AF:
0.412
AC:
2131
AN:
5174
South Asian (SAS)
AF:
0.476
AC:
2290
AN:
4812
European-Finnish (FIN)
AF:
0.447
AC:
4734
AN:
10584
Middle Eastern (MID)
AF:
0.527
AC:
155
AN:
294
European-Non Finnish (NFE)
AF:
0.491
AC:
33385
AN:
67948
Other (OTH)
AF:
0.507
AC:
1072
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1925
3850
5774
7699
9624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
674
1348
2022
2696
3370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.499
Hom.:
80125
Bravo
AF:
0.515
Asia WGS
AF:
0.443
AC:
1546
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
3.7
DANN
Benign
0.53
PhyloP100
0.10
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4512966;
hg19: chr13-111082058;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.